35岁女子患“心脏病绝症”，医生为其植入“终极救命武器”

Core Viewpoint - The article highlights a significant medical advancement in treating end-stage dilated cardiomyopathy through the implantation of a left ventricular assist device (LVAD), which has dramatically improved the patient's quality of life and heart function [3][10]. Group 1: Patient Condition and Treatment - A 35-year-old woman suffering from end-stage dilated cardiomyopathy faced severe limitations in her daily life due to heart failure, which is often referred to as the "terminal illness of heart disease" [3][4]. - Traditional treatments were ineffective, and heart transplantation faced challenges due to donor shortages, leaving the patient with little hope [3][4]. - The medical team at Tsinghua University First Affiliated Hospital, led by Professor Zhang Mingkui, performed a critical surgery to implant an LVAD, providing the patient with a chance for recovery [3][5]. Group 2: Surgical Procedure - The LVAD implantation is described as a "last-resort lifesaving weapon" for end-stage heart failure patients, requiring high technical skill and coordination among the surgical team [5][6]. - The procedure involved precise placement of inflow and outflow conduits within the heart while it continued to beat, ensuring long-term patency with the aorta [5][6]. - The surgery utilized a third-generation magnetic levitation LVAD, which is smaller and less invasive, promoting better postoperative recovery [5][6]. Group 3: Postoperative Care and Recovery - After surgery, the patient was closely monitored in the cardiac intensive care unit, focusing on managing circulation, respiration, coagulation, and infection prevention [7][9]. - The patient transitioned to a regular ward for individualized anticoagulation therapy and gradual rehabilitation training [7][9]. - Follow-up three months post-surgery showed significant improvements in heart function, with the left ventricular end-diastolic diameter reducing by 15mm and ejection fraction increasing from 25% to 50% [10]. Group 4: Impact on Quality of Life - Six months after the surgery, the patient experienced a remarkable transformation, regaining independence and the ability to engage in daily activities [10]. - The LVAD not only supported her heart function but also restored her quality of life, allowing her to plan for a future not dominated by illness [10]. - Professor Zhang Mingkui emphasized the importance of ensuring that every end-stage heart failure patient can live with quality, reflecting a commitment to both technological advancement and respect for life [10].